Management of symptomatic uncomplicated diverticular disease (SUDD) of the colon with Clostridium butyricum CBM588 versus rifaximin: a retrospective cross-sectional study

Riccardo Urgesi, Cristiano Pagnini, Fernando De Angelis, Amjad Khan, Lorella Pallotta, Gianfranco Fanello, Pavlos Antypas, Maria Carla Di Paolo, Giuseppe Villotti, Alexander Bertuccioli, Davide Sisti, Francesco Di Pierro, Nicola Zerbinati, Maria Giovanna Graziani

Open source

DOI: 10.1007/s00384-025-05005-6
Published: 2025-10-18
Container: International Journal of Colorectal Disease
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00384-025-05005-6,
  title = {Management of symptomatic uncomplicated diverticular disease (SUDD) of the colon with Clostridium butyricum CBM588 versus rifaximin: a retrospective cross-sectional study},
  author = {Riccardo Urgesi and Cristiano Pagnini and Fernando De Angelis and Amjad Khan and Lorella Pallotta and Gianfranco Fanello and Pavlos Antypas and Maria Carla Di Paolo and Giuseppe Villotti and Alexander Bertuccioli and Davide Sisti and Francesco Di Pierro and Nicola Zerbinati and Maria Giovanna Graziani},
  year = {2025},
  journal = {International Journal of Colorectal Disease},
  doi = {10.1007/s00384-025-05005-6},
  url = {https://doi.org/10.1007/s00384-025-05005-6}
}

RIS

TY  - JOUR
TI  - Management of symptomatic uncomplicated diverticular disease (SUDD) of the colon with Clostridium butyricum CBM588 versus rifaximin: a retrospective cross-sectional study
AU  - Riccardo Urgesi
AU  - Cristiano Pagnini
AU  - Fernando De Angelis
AU  - Amjad Khan
AU  - Lorella Pallotta
AU  - Gianfranco Fanello
AU  - Pavlos Antypas
AU  - Maria Carla Di Paolo
AU  - Giuseppe Villotti
AU  - Alexander Bertuccioli
AU  - Davide Sisti
AU  - Francesco Di Pierro
AU  - Nicola Zerbinati
AU  - Maria Giovanna Graziani
PY  - 2025
JO  - International Journal of Colorectal Disease
DO  - 10.1007/s00384-025-05005-6
UR  - https://doi.org/10.1007/s00384-025-05005-6
ER  -

APA

Urgesi, R., Pagnini, C., Angelis, F. D., Khan, A., Pallotta, L., Fanello, G., Antypas, P., Paolo, M. C. D., Villotti, G., Bertuccioli, A., Sisti, D., Pierro, F. D., Zerbinati, N., & Graziani, M. G. (2025). Management of symptomatic uncomplicated diverticular disease (SUDD) of the colon with Clostridium butyricum CBM588 versus rifaximin: a retrospective cross-sectional study. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-025-05005-6

Source records

crossref · retrieved 2026-09-26T00:49:29.997Z